Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.82
TRNX's Cash to Debt is ranked higher than
54% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 6.28 vs. TRNX: 0.82 )
TRNX' s 10-Year Cash to Debt Range
Min: 0.18   Max: 1.37
Current: 0.82

0.18
1.37
Equity to Asset 0.75
TRNX's Equity to Asset is ranked higher than
79% of the 358 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. TRNX: 0.75 )
TRNX' s 10-Year Equity to Asset Range
Min: 0.42   Max: 0.79
Current: 0.75

0.42
0.79
F-Score: 4
Z-Score: 3.01
M-Score: -2.81
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -7.74
TRNX's Operating margin (%) is ranked higher than
54% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. TRNX: -7.74 )
TRNX' s 10-Year Operating margin (%) Range
Min: -16.1   Max: -2.74
Current: -7.74

-16.1
-2.74
Net-margin (%) -11.71
TRNX's Net-margin (%) is ranked higher than
53% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 4.82 vs. TRNX: -11.71 )
TRNX' s 10-Year Net-margin (%) Range
Min: -27.11   Max: -7.84
Current: -11.71

-27.11
-7.84
ROE (%) -6.93
TRNX's ROE (%) is ranked higher than
56% of the 365 Companies
in the Global Medical Devices industry.

( Industry Median: 5.79 vs. TRNX: -6.93 )
TRNX' s 10-Year ROE (%) Range
Min: -24.85   Max: -4.99
Current: -6.93

-24.85
-4.99
ROA (%) -5.16
TRNX's ROA (%) is ranked higher than
56% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. TRNX: -5.16 )
TRNX' s 10-Year ROA (%) Range
Min: -10.5   Max: -3.32
Current: -5.16

-10.5
-3.32
ROC (Joel Greenblatt) (%) -17.40
TRNX's ROC (Joel Greenblatt) (%) is ranked higher than
56% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 12.55 vs. TRNX: -17.40 )
TRNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -20.92   Max: -5.5
Current: -17.4

-20.92
-5.5
Revenue Growth (%) -6.10
TRNX's Revenue Growth (%) is ranked higher than
56% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. TRNX: -6.10 )
TRNX' s 10-Year Revenue Growth (%) Range
Min: -6.1   Max: -2.7
Current: -6.1

-6.1
-2.7
EPS Growth (%) -17.80
TRNX's EPS Growth (%) is ranked higher than
61% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: -2.80 vs. TRNX: -17.80 )
TRNX' s 10-Year EPS Growth (%) Range
Min: -38.1   Max: -17.8
Current: -17.8

-38.1
-17.8
» TRNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

TRNX Guru Trades in Q1 2013

Paul Tudor Jones 400,000 sh (New)
Steven Cohen 700,226 sh (+8.17%)
» More
Q2 2013

TRNX Guru Trades in Q2 2013

Steven Cohen 838,574 sh (+19.76%)
Paul Tudor Jones 475,000 sh (+18.75%)
» More
Q3 2013

TRNX Guru Trades in Q3 2013

Jim Simons 61,400 sh (New)
Paul Tudor Jones Sold Out
Steven Cohen 530,855 sh (-36.7%)
» More
Q4 2013

TRNX Guru Trades in Q4 2013

Jim Simons Sold Out
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with TRNX



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.70
TRNX's P/B is ranked higher than
81% of the 355 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. TRNX: 1.70 )
TRNX' s 10-Year P/B Range
Min: 1.47   Max: 2.66
Current: 1.7

1.47
2.66
P/S 2.70
TRNX's P/S is ranked higher than
55% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. TRNX: 2.70 )
TRNX' s 10-Year P/S Range
Min: 2.22   Max: 3.91
Current: 2.7

2.22
3.91
EV-to-EBIT 333.30
TRNX's EV-to-EBIT is ranked lower than
80% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 20.91 vs. TRNX: 333.30 )
TRNX' s 10-Year EV-to-EBIT Range
Min: 641.6   Max: 1265.7
Current: 333.3

641.6
1265.7

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.70
TRNX's Price/Tangible Book is ranked lower than
58% of the 328 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. TRNX: 5.70 )
TRNX' s 10-Year Price/Tangible Book Range
Min: 4.08   Max: 10.05
Current: 5.7

4.08
10.05
Price/Median PS Value 1.00
TRNX's Price/Median PS Value is ranked higher than
69% of the 338 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. TRNX: 1.00 )
TRNX' s 10-Year Price/Median PS Value Range
Min: 0.88   Max: 1
Current: 1

0.88
1
Earnings Yield (Greenblatt) 0.30
TRNX's Earnings Yield (Greenblatt) is ranked lower than
68% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. TRNX: 0.30 )
TRNX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.3
Current: 0.3

0.1
0.3

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:T98.Germany
Tornier N.V. focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot.
» More Articles for NAS:TRNX

Headlines

Articles On GuruFocus.com
No related article found.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide